This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: JIPMER 2018, Subject name: Pharmacology
Which of the following statement is false about drugs used in rheumatoid ahritis? 
Select and explain. 
A. Tofacitinib inhibits JAK1 and JAK3, B. Tocilizumab inhibits IL-6, C. Tofactinib is given intravenously, D. Tocilizumab is given by intravenous and subcutaneous route
C: Tofactinib is given intravenously
Answer: C: Tofactinib is given intravenously 
Explanation: Drug ending with inib - JAK inhibitor and given orally.- Tofacitinib- Beracitinib Drug ending with Mab: - Monoclonal antibody and IL-6 inhibitor.- Tocilizumab- SarilumabSix : IL-6A-AhritisR-RheumatoidI - InterleukinL - InterleukinUMAB: Monoclonal Antibody.All above mentioned drugs are used for Rheumatoid ahritis. Tocilizumab: is also use for cytokine release syndrome.